DOCSLIB.ORG

748434V1.Full.Pdf

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
748434V1.Full.Pdf bioRxiv preprint doi: https://doi.org/10.1101/748434; this version posted August 28, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. 1 Sensitive detection of highly fragmented cytomegalovirus nucleic acid in human cfDNA 2 3 Vikas Peddu1,%, Benjamin T. Bradley1,%, R. Swati Shree2, Brice G. Colbert1, Hong Xie1, Tracy K. 4 Santo1, Meei-Li Huang1, Edith Y. Cheng2, Eric Konnick1, Stephen J. Salipante1, Keith R. 5 Jerome1,3, Christina M. Lockwood1, Alexander L. Greninger1,3,# 6 7 1Department of Laboratory Medicine, University of Washington, Seattle, WA, USA 8 2Department of Obstetrics and Gynecology, University of Washington, Seattle, WA, USA 9 3Fred Hutchinson Cancer Research Center, Seattle, WA, USA 10 %These authors contributed equally to this work. 11 #corresponding author, Alexander L. Greninger, [email protected] 12 13 Keywords: human cytomegalovirus, CMV, cfDNA, NIPT, sequencing 14 Abstract word count: 247 15 Main text word count: 4313 16 17 bioRxiv preprint doi: https://doi.org/10.1101/748434; this version posted August 28, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. 18 Abstract 19 Congenital human cytomegalovirus (CMV) infections are the leading cause of newborn 20 hearing and central nervous system impairments worldwide. Currently, routine prenatal 21 screening for congenital CMV is not performed in the United States and confirmation in 22 suspected perinatal cases requires invasive sampling by amniocentesis. We hypothesized that 23 detection of CMV from maternal cell-free DNA (cfDNA) plasma could provide a non-invasive 24 indicator of congenital CMV infection. We analyzed sequence data from 2,208 individuals 25 undergoing routine non-invasive prenatal aneuploidy screening at the University of Washington. 26 CMV reads were identified in 117 (5.3%) samples. Positive samples were stratified based on 27 CMV reads per million sample reads (RPM), resulting in ten samples being classified as strong 28 positive (RPM > 0.3) and 107 as intermediate positive (0.01<RPM<0.3). Subsequent qPCR 29 testing identified CMV in 9/10 strong positive samples and 2/32 intermediate positive samples. 30 Median cfDNA insert size derived from CMV was significantly shorter than cfDNA derived from 31 human chromosomes (103 vs 172 bp, p<0.0001), corresponding to the 3rd percentile of human 32 cfDNA insert size. In addition, CMV cfDNA fragment lengths were distributed over a wider range 33 than human cfDNA reads. These studies reveal the highly fragmented nature of CMV cfDNA 34 and offer precise measurements of its length: these features likely explain discrepancies in 35 serum CMV viral loads measurements determined by different qPCR assays, despite 36 widespread efforts to standardize results. More work is required to determine how detection of 37 CMV from maternal cfDNA can be best used as tool for congenital CMV screening or diagnosis. bioRxiv preprint doi: https://doi.org/10.1101/748434; this version posted August 28, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. 38 Introduction 39 Human cytomegalovirus (CMV) is the most common cause of congenital defects in the 40 United States and affects roughly 0.5-1.3% of live births worldwide (1, 2), causing more 41 congenital disease than all disorders tested for in newborn screening combined (4). Congenital 42 CMV is associated with a variety of late-onset permanent disabilities such as hearing loss, 43 microcephaly, vision defects, and intellectual deficits (3). Primary maternal CMV infection is 44 associated with a 40% risk of fetal infection, whereas recurrent infection has an approximately 45 1% transmission rate (3). The high prevalence of recurrent infection means that recurrent 46 disease is the cause of nearly three-quarters of congenital CMV cases (3). Despite the 47 incredible burden of congenital disease, existing methods to screen for fetal CMV infection are 48 limiting in multiple important respects, including a lack of sensitivity and delayed identification of 49 affected patients. 50 Due to the significant risks posed by primary congenital CMV, prenatal CMV screening 51 via maternal serology has been proposed as an attractive approach to limit the incidence of 52 disease in this population (5). Yet, a variety issues can arise during interpretation of serology 53 results, making diagnosis challenging (6–9). Additionally, the utility of serologic screening is 54 limited to mothers with primary infections, thus excluding the substantial majority of congenital 55 CMV cases that are associated with maternal reactivation or reinfection. Consequently, the 56 current gold standard for diagnosing congenital CMV infection prenatally is amniocentesis, an 57 invasive procedure best performed after 21 weeks gestation. Because of the risks associated 58 with this procedure, amniocentesis is considered following radiologic and/or serologic evidence 59 for congenital disease (10–12). 60 If not diagnosed antenatally, additional cases of congenital CMV are identified by testing 61 for viral DNA in newborn saliva or urine within the first three weeks following a failed hearing 62 screen or other concerning clinical characteristics (13). Although this is an important strategy to 63 enable early intervention, the underlying developmental abnormalities are already established at bioRxiv preprint doi: https://doi.org/10.1101/748434; this version posted August 28, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. 64 the time of testing and only demonstrate a modest response to antiviral treatment (14). Further 65 limiting the impact of this approach is the observation that over half of congenital CMV cases 66 manifest symptoms months to years after birth (15). In cases where delayed symptom onset is 67 suspected, the diagnosis of congenital CMV infection is limited to retrospective testing of stored 68 heel stick blood spots since PCR testing for CMV viremia after three weeks of life cannot 69 exclude disease secondary to postnatal infection (16). In summary, the current landscape of 70 congenital CMV screening is hindered by insensitive tools and delayed identification of cases. 71 Non-invasive prenatal testing (NIPT) via maternal cell-free DNA (cfDNA) has already 72 revolutionized the ability to screen for fetal aneuploidies, subchromosomal copy number 73 alterations, and other genetic diseases (17, 18). CMV have previously been detected in cfDNA 74 sequencing data, including NIPT (19). At our institution, we have performed clinical screening 75 for fetal aneuploidies by cfDNA since May 2017. As currently available non-invasive screening 76 methods for congenital CMV infection are fraught with error and uncertainty, leveraging prenatal 77 cfDNA sequencing would provide a new non-invasive approach for examining CMV disease 78 burden and predicting clinical outcomes. 79 80 Methods 81 Study population 82 We included all maternal plasma samples collected between May 2017 to November 2018 for 83 clinically-indicated aneuploidy screening performed at the University of Washington Department 84 of Laboratory Medicine. The 2,208 cfDNA samples in our cohort were derived from pregnant 85 women in the University of Washington (UW) Medicine network. Of these, 727 tests were 86 performed during validation and 1,481 tests were performed during the clinical implementation 87 phase. Metadata was available for the 1,325 patients (1,481 tests) screened during the clinical 88 implementation phase (Supplementary Table 1). A minimum gestational age of 10 weeks was 89 required for testing. Following University of Washington Institutional Review Board review and bioRxiv preprint doi: https://doi.org/10.1101/748434; this version posted August 28, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. 90 approval, maternal and neonatal clinical histories were gathered for those samples with a CMV 91 cfDNA reads per million sample reads (RPM) > 0.3 (10 samples, 9 patients) or those with a 92 CMV cfDNA RPM < 0.3 and a positive qPCR result (2 samples, 2 patients). We collected 93 maternal age, gravidity, parity, preexisting comorbidities, and results from ultrasound studies. 94 Neonatal information included gestational age at birth, birth weight, APGAR scores, and mode 95 of delivery. Additional information gathered from the antenatal period included admission to the 96 neonatal intensive care unit (NICU), length of stay, and any infectious disease testing 97 performed. Given the available cfDNA data, we also included maternal and placental cfDNA 98 fractions and the number of total reads. 99 100 Non-invasive cell-free DNA sequencing 101 cfDNA reads from maternal plasma were generated through a validated, laboratory-developed 102 method used to screen for fetal aneuploidies and copy number alterations. For sample 103 preparation, whole blood from Streck (BCT1) tubes was centrifuged and plasma was isolated as 104 per the package insert. cfDNA was extracted from plasma using the QIAsymphony Circulating 105 DNA Kit. Following measurement of the DNA concentration in the eluate, next-generation 106 sequencing library preparation was performed on the BioMek 4000 using the KAPA HyperPrep 107 kit for adapter and index ligation. The library was purified using the Agencourt AMPureXP kit 108 prior to amplification.
Load more

Recommended publications
  • And Toxoplasmosis in Jackass Penguins in South Africa
    IMMUNOLOGICAL SURVEY OF BABESIOSIS (BABESIA PEIRCEI) AND TOXOPLASMOSIS IN JACKASS PENGUINS IN SOUTH AFRICA GRACZYK T.K.', B1~OSSY J.].", SA DERS M.L. ', D UBEY J.P.···, PLOS A .. ••• & STOSKOPF M. K .. •••• Sununary : ReSlIlIle: E x-I1V\c n oN l~ lIrIUSATION D'Ar\'"TIGENE DE B ;IB£,'lA PH/Re El EN ELISA ET simoNi,cATIVlTli t'OUR 7 bxo l'l.ASMA GONIJfI DE SI'I-IENICUS was extracted from nucleated erythrocytes Babesia peircei of IJEMIiNSUS EN ArRIQUE D U SUD naturally infected Jackass penguin (Spheniscus demersus) from South Africo (SA). Babesia peircei glycoprotein·enriched fractions Babesia peircei a ele extra it d 'erythrocytes nue/fies p,ovenanl de Sphenicus demersus originoires d 'Afrique du Sud infectes were obto ined by conca navalin A-Sepharose affinity column natulellement. Des fractions de Babesia peircei enrichies en chromatogrophy and separated by sod ium dodecyl sulphate­ glycoproleines onl ele oblenues par chromatographie sur colonne polyacrylam ide gel electrophoresis (SDS-PAGE ). At least d 'alfinite concona valine A-Sephorose et separees par 14 protein bonds (9, 11, 13, 20, 22, 23, 24, 43, 62, 90, electrophorese en gel de polyacrylamide-dodecylsuJfale de sodium 120, 204, and 205 kDa) were observed, with the major protein (SOS'PAGE) Q uotorze bandes proleiques au minimum ont ete at 25 kDa. Blood samples of 191 adult S. demersus were tes ted observees (9, 1 I, 13, 20, 22, 23, 24, 43, 62, 90, 120, 204, by enzyme-linked immunosorbent assoy (ELISA) utilizing B. peircei et 205 Wa), 10 proleine ma;eure elant de 25 Wo.
    [Show full text]
  • Neglected Parasitic Infections in the United States Toxoplasmosis
    Neglected Parasitic Infections in the United States Toxoplasmosis Toxoplasmosis is a preventable disease caused by the parasite Toxoplasma gondii. An infected individual can experience fever, malaise, and swollen lymph nodes, but can also show no signs or symptoms. A small number of infected persons may experience eye disease, and infection during pregnancy can lead to miscarriage or severe disease in the newborn, including developmental delays, blindness, and epilepsy. Once infected with T. gondii, people are generally infected for life. As a result, infected individuals with weakened immune systems—such as in the case of advanced HIV disease, during cancer treatment, or after organ transplant—can experience disease reactivation, which can result in severe illness or even death. In persons with advanced HIV disease, inflammation of the brain (encephalitis) due to toxoplasmosis is common unless long-term preventive medication is taken. Researchers have also found an association of T. gondii infection with the risk for mental illness, though this requires further study. Although T. gondii can infect most warm-blooded animals, cats are the only host that shed an environmentally resistant form of the organism (oocyst) in their feces. Once a person or another warm-blooded animal ingests the parasite, it becomes infectious and travels through the wall of the intestine. Then the parasite is carried by blood to other tissues including the muscles and central nervous system. Humans can be infected several ways, including: • Eating raw or undercooked meat containing the parasite in tissue cysts (usually pork, lamb, goat, or wild game meat, although beef and field-raised chickens have been implicated in studies).
    [Show full text]
  • Oxidative Stress As a Possible Target in the Treatment of Toxoplasmosis: Perspectives and Ambiguities
    International Journal of Molecular Sciences Review Oxidative Stress as a Possible Target in the Treatment of Toxoplasmosis: Perspectives and Ambiguities Karolina Szewczyk-Golec , Marta Pawłowska , Roland Wesołowski , Marcin Wróblewski and Celestyna Mila-Kierzenkowska * Department of Medical Biology and Biochemistry, Ludwik Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toru´n,24 Karłowicza St, 85-092 Bydgoszcz, Poland; [email protected] (K.S.-G.); [email protected] (M.P.); [email protected] (R.W.); [email protected] (M.W.) * Correspondence: [email protected]; Tel.: +48-52-585-37-37 Abstract: Toxoplasma gondii is an apicomplexan parasite causing toxoplasmosis, a common disease, which is most typically asymptomatic. However, toxoplasmosis can be severe and even fatal in immunocompromised patients and fetuses. Available treatment options are limited, so there is a strong impetus to develop novel therapeutics. This review focuses on the role of oxidative stress in the pathophysiology and treatment of T. gondii infection. Chemical compounds that modify redox status can reduce the parasite viability and thus be potential anti-Toxoplasma drugs. On the other hand, oxidative stress caused by the activation of the inflammatory response may have some deleterious consequences in host cells. In this respect, the potential use of natural antioxidants Citation: Szewczyk-Golec, K.; is worth considering, including melatonin and some vitamins, as possible novel anti-Toxoplasma Pawłowska, M.; Wesołowski, R.; therapeutics. Results of in vitro and animal studies are promising. However, supplementation with Wróblewski, M.; Mila-Kierzenkowska, some antioxidants was found to promote the increase in parasitemia, and the disease was then C.
    [Show full text]
  • Control of Intestinal Protozoa in Dogs and Cats
    Control of Intestinal Protozoa 6 in Dogs and Cats ESCCAP Guideline 06 Second Edition – February 2018 1 ESCCAP Malvern Hills Science Park, Geraldine Road, Malvern, Worcestershire, WR14 3SZ, United Kingdom First Edition Published by ESCCAP in August 2011 Second Edition Published in February 2018 © ESCCAP 2018 All rights reserved This publication is made available subject to the condition that any redistribution or reproduction of part or all of the contents in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise is with the prior written permission of ESCCAP. This publication may only be distributed in the covers in which it is first published unless with the prior written permission of ESCCAP. A catalogue record for this publication is available from the British Library. ISBN: 978-1-907259-53-1 2 TABLE OF CONTENTS INTRODUCTION 4 1: CONSIDERATION OF PET HEALTH AND LIFESTYLE FACTORS 5 2: LIFELONG CONTROL OF MAJOR INTESTINAL PROTOZOA 6 2.1 Giardia duodenalis 6 2.2 Feline Tritrichomonas foetus (syn. T. blagburni) 8 2.3 Cystoisospora (syn. Isospora) spp. 9 2.4 Cryptosporidium spp. 11 2.5 Toxoplasma gondii 12 2.6 Neospora caninum 14 2.7 Hammondia spp. 16 2.8 Sarcocystis spp. 17 3: ENVIRONMENTAL CONTROL OF PARASITE TRANSMISSION 18 4: OWNER CONSIDERATIONS IN PREVENTING ZOONOTIC DISEASES 19 5: STAFF, PET OWNER AND COMMUNITY EDUCATION 19 APPENDIX 1 – BACKGROUND 20 APPENDIX 2 – GLOSSARY 21 FIGURES Figure 1: Toxoplasma gondii life cycle 12 Figure 2: Neospora caninum life cycle 14 TABLES Table 1: Characteristics of apicomplexan oocysts found in the faeces of dogs and cats 10 Control of Intestinal Protozoa 6 in Dogs and Cats ESCCAP Guideline 06 Second Edition – February 2018 3 INTRODUCTION A wide range of intestinal protozoa commonly infect dogs and cats throughout Europe; with a few exceptions there seem to be no limitations in geographical distribution.
    [Show full text]
  • No Association Between Current Depression and Latent Toxoplasmosis in Adults
    Institute of Parasitology, Biology Centre CAS Folia Parasitologica 2016, 63: 032 doi: 10.14411/fp.2016.032 http://folia.paru.cas.cz Research Article No association between current depression and latent toxoplasmosis in adults Shawn D. Gale1,2, Andrew N. Berrett1, Bruce Brown1, Lance D. Erickson3 and Dawson W. Hedges1,2 1 Department of Psychology, Brigham Young University, Provo, Utah, USA; 2 The Neuroscience Center, Brigham Young University, Provo, Utah, USA; 3 Department of Sociology, Brigham Young University, Provo, Utah, USA Abstract: Changes in behaviour and cognition have been associated with latent infection from the apicomplexan protozoan Toxoplas- ma gondii (Nicolle et Manceaux, 1908) in both animal and human studies. Further, neuropsychiatric disorders such as schizophrenia have also been associated with latent toxoplasmosis. Previously, we found no association between T. gondii immunoglobulin G anti- body (IgG) seropositivity and depression in human adults between the ages of 20 and 39 years (n = 1 846) in a sample representative of the United States collected by the Centers for Disease Control as part of a National Health and Nutrition Examination Survey (NHANES) from three datasets collected between 1999–2004. In the present study, we used NHANES data collected between 2009 and 2012 that included subjects aged 20 to 80 years (n = 5 487) and used the Patient Health Questionnaire 9 (PHQ-9) to assess depres- sion with the overall aim of testing the stability of the results of the prior study. In the current study, the seroprevalence of T. gondii was 13%. The percentage of subjects reporting clinical levels of depression assessed with the PHQ-9 was 8%.
    [Show full text]
  • Sero Burden of Toxoplasma Gondii and Associated Risk Factors Among HIV Infected Persons in Armed Forces Referral and Teaching Hospital, Addis Ababa, Ethiopia
    iseas al D es ic & p P u ro b T l f i c o l H a e Journal of Tropical Diseases and Public a n r l t u h o J ISSN: 2329-891X Health Research Article Sero Burden of Toxoplasma gondii and Associated Risk Factors among HIV Infected Persons in Armed Forces Referral and Teaching Hospital, Addis Ababa, Ethiopia Fewzia Mohammed1,2*, Mulusew Alemneh Sinishaw3,4, Negash Nurahmed1, Shemsu Kedir Juhar1, Kassu Desta5 1Ethiopian Public Health Institute, Addis Ababa, Ethiopia; 2Armed forces Referral and Teaching Hospital, Addis Ababa, Ethiopia; 3Clinical Chemistry Department, College of Medicine and Health Sciences, Bahir Dar University, Bahir Dar, Ethiopia; 4Clinical Chemistry Department, Amhara Public Health Institute, Bahir Dar, Ethiopia; 5School of Allied Health Science, Department of Medical Laboratory Sciences, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia ABSTRACT Background: Toxoplasmosis is a zoonotic disease, worldwide distribution caused by an obligate intracellular coccidian parasite, known as Toxoplasma gondii. T. gondii can lead to serious diseases in immuno-compromised patients such as HIV/AIDS patients. In most cases, central nervous system involvement can lead to encephalitis, which is one of the most important reasons for death among patients with HIV due to reactivation of tissue cysts that remained latent after the primary infection. This study was conducted to assess the sero burden of Toxoplasma gondii infection and identify associated risk factors among HIV infected individuals in Armed Forces Referral and Teaching Hospital, Addis Ababa, Ethiopia. Methods: A cross-sectional study was conducted from March to May 2016. After getting an informed consent a pretested questionnaire was used to gather socio-demographic information and data on factors predisposing to T.
    [Show full text]
  • Cellular Cullin RING Ubiquitin Ligases: Druggable Host Dependency Factors of Cytomegaloviruses
    International Journal of Molecular Sciences Review Cellular Cullin RING Ubiquitin Ligases: Druggable Host Dependency Factors of Cytomegaloviruses Tanja Becker, Vu Thuy Khanh Le-Trilling and Mirko Trilling * Institute for Virology, University Hospital Essen, University Duisburg-Essen, 45147 Essen, Germany; [email protected] (T.B.); [email protected] (V.T.K.L.-T.) * Correspondence: [email protected]; Tel.: +49-(0)201-723-83830 Received: 15 March 2019; Accepted: 28 March 2019; Published: 2 April 2019 Abstract: Human cytomegalovirus (HCMV) is a ubiquitous betaherpesvirus that frequently causes morbidity and mortality in individuals with insufficient immunity, such as transplant recipients, AIDS patients, and congenitally infected newborns. Several antiviral drugs are approved to treat HCMV infections. However, resistant HCMV mutants can arise in patients receiving long-term therapy. Additionally, side effects and the risk to cause birth defects limit the use of currently approved antivirals against HCMV. Therefore, the identification of new drug targets is of clinical relevance. Recent work identified DNA-damage binding protein 1 (DDB1) and the family of the cellular cullin (Cul) RING ubiquitin (Ub) ligases (CRLs) as host-derived factors that are relevant for the replication of human and mouse cytomegaloviruses. The first-in-class CRL inhibitory compound Pevonedistat (also called MLN4924) is currently under investigation as an anti-tumor drug in several clinical trials. Cytomegaloviruses exploit CRLs to regulate the abundance of viral proteins, and to induce the proteasomal degradation of host restriction factors involved in innate and intrinsic immunity. Accordingly, pharmacological blockade of CRL activity diminishes viral replication in cell culture.
    [Show full text]
  • Food and Waterborne Parasitology 16 (2019) E00058
    Food and Waterborne Parasitology 16 (2019) e00058 Contents lists available at ScienceDirect Food and Waterborne Parasitology journal homepage: www.elsevier.com/locate/fawpar Prevention and mitigation of congenital toxoplasmosis. Economic costs and benefits in diverse settings Branko Bobić a,⁎, Isabelle Villena b, Eileen Stillwaggon c a Institute for Medical Research, University of Belgrade, Centre of Excellence for Food- and Vector-borne Zoonoses, National Reference Laboratory for Toxoplasmosis, Serbia b EA 7510, UFR Médecine, University Reims Champagne-Ardenne, National Reference Center on Toxoplasmosis, Hospital Reims, France c Department of Economics, Gettysburg College, Gettysburg, PA, USA article info abstract Article history: Congenital toxoplasmosis (CT), the result of a primary infection of pregnant women with Toxo- Received 20 December 2018 plasma gondii which was transmitted to the fetus, may result in mild to deep injuries occurring Received in revised form 13 May 2019 in the newborn or later in its development or in adolescence. The visual and cognitive impair- Accepted 13 May 2019 ment that can result imposes substantial economic costs on the individual and society. Numer- Available online xxxx ous observational studies favor the conclusion that, with preventive measures currently available, it is possible to reduce the incidence of infections in pregnant women, the incidence Keywords: of fetal infection by preventing transplacental transmission, and the gravity of injury in infected Congenital toxoplasmosis newborns. Treatment of infected newborns can also reduce the severity of consequences and Prevention the frequency of their occurrence later in life. Prevention programs, however, are applied in Screening Economic costs only a few countries; in most countries implementation of a national prevention program Economic benefits has not been considered or has been thought to be too expensive.
    [Show full text]
  • The Impact of Toxoplasma Gondii Infection on the Vitamin D3 Levels Among Women in Childbearing Age in Kirkuk Province-Iraq
    Open Journal of Medical Microbiology, 2019, 9, 151-167 https://www.scirp.org/journal/ojmm ISSN Online: 2165-3380 ISSN Print: 2165-3372 The Impact of Toxoplasma gondii Infection on the Vitamin D3 Levels among Women in Childbearing Age in Kirkuk Province-Iraq Faten Ayoob Tayeb1, Yahay Jirjees Salman2*, Khalidha Mohammad Ameen3 1Biology Department, M.Sc. College of Science-Kirkuk University, Kirkuk, Iraq 2Department of Medical Microbiology and Immunology, Ph.D. Microbiology, Kirkuk Medical College, Kirkuk, Iraq 3Department of Gynecology and Obstetric-Kirkuk Medical College, Ph.D. Gynecology and Obstetric, Kirkuk Medical College, Kirkuk, Iraq How to cite this paper: Tayeb, F.A., Sal- Abstract man, Y.J. and Ameen, K.M. (2019) The Impact of Toxoplasma gondii Infection on Background: Toxoplasmosis had a remarked role in disturbing pregnancy in the Vitamin D3 Levels among Women in women by abortions and congenital abnormalities outcome .Vitamin D defi- Childbearing Age in Kirkuk Province-Iraq. ciency had a role in bone fragility, osteoporosis, exposing women to fractures Open Journal of Medical Microbiology, 9, as well as to bone deformities in newborns. Objective: To assess the rela- 151-167. https://doi.org/10.4236/ojmm.2019.94015 tionship between toxoplasmosis seropositivity and vitamin D abnormalities in sera of women in childbearing ages using ELISA and auto-analyzers. Me- Received: September 5, 2019 thodology: A cross-sectional study was conducted by examining the sera of Accepted: November 29, 2019 153 women, who visited Azadi Teaching Hospital Gynecological and Obste- Published: December 2, 2019 tric Clinics. Their complaints involve signs of bad obstetric history (BOH) Copyright © 2019 by author(s) and and bone disorders, versus to 46 women negative for (BOH).
    [Show full text]
  • Slide 1 This Lecture Is the Second Part of the Protozoal Parasites. in This LECTURE We Will Talk About the Apicomplexans SPECIFICALLY the Coccidians
    Slide 1 This lecture is the second part of the protozoal parasites. In this LECTURE we will talk about the Apicomplexans SPECIFICALLY THE Coccidians. In the next lecture we will Lecture 8: Emerging Parasitic Protozoa part 1 (Apicomplexans-1: talk about the Plasmodia and Babesia Coccidia) Presented by Sharad Malavade, MD, MPH Original Slides by Matt Tucker, PhD HSC4933 1 Emerging Infectious Diseases Slide 2 These are the readings for this week. Readings-Protozoa pt. 2 (Coccidia) • Ch.8 (p. 183 [table 8.3]) • Ch. 11 (p. 301, 304-305) 2 Slide 3 Monsters Inside Me • Cryptosporidiosis (Cryptosporidum spp., Coccidian/Apicomplexan): Background: http://www.cdc.gov/parasites/crypto/ Video: http://animal.discovery.com/videos/monsters-inside-me- cryptosporidium-outbreak.html http://animal.discovery.com/videos/monsters-inside-me-the- cryptosporidium-parasite.html Toxoplasmosis (Toxoplasma gondii, Coccidian/Apicomplexan) Background: http://www.cdc.gov/parasites/toxoplasmosis/ Video: http://animal.discovery.com/videos/monsters-inside-me- toxoplasma-parasite.html 3 Slide 4 Learning objectives: Apicomplexan These are the learning objectives for this lecture. coccidia • Define basic attributes of Apicomplexans- unique characteristics? • Know basic life cycle and developmental stages of coccidian parasites • Required hosts – Transmission strategy – Infective and diagnostic stages – Unique character of reproduction • Know the common characteristics of each parasite – Be able to contrast and compare • Define diseases, high-risk groups • Determine diagnostic methods, treatment • Know important parasite survival strategies • Be familiar with outbreaks caused by coccidians and the conditions involved 4 Slide 5 This figure from the last lecture is just to show you the Taxonomic Review apicoplexans. This lecture we talk about the Coccidians.
    [Show full text]
  • What Is Babesiosis? by BRIDGET PARSH, Edd, MSN, RN, CNS, and KAITLYN WHITNEY
    Infection Prevention What is babesiosis? BY BRIDGET PARSH, EdD, MSN, RN, CNS, AND KAITLYN WHITNEY RIMARILY CAUSED BY experience nausea, emesis, night history, such as a recent tick bite, the protozoan parasite sweats, headache, dry cough, weight blood transfusion, or trip to an Babesia microti in the US, loss, anemia, and hematuria.2,9-11 endemic area.1,5 Babesia can be P babesiosis is an infec- Although most asymptomatic detected inside RBCs via blood tion that destroys red blood cells patients do not require treatment, smear in the first 2 weeks of (RBCs).1 In the US, it is endemic symptomatic patients usually infection.10,11 Antibody testing can to the Northeast and upper Mid- require antimicrobial treatment confirm the diagnosis.5 The poly- west and typically transmitted by for 7 to 10 days with combination merase chain reaction assay, the deer tick, Ixodes scapularis.1-5 atovaquone and azithromycin or immunofluorescence antibody test, However, the transmitting species clindamycin and quinine.2 and fluorescent in situ hybridization of babesiosis can vary globally. This Babesiosis can be a severe and assay can each detect antibodies bloodborne infection can also be life-threatening infection for older related to the infection.2,13,14 transmitted by an infected donor adults and immunocompromised It may be necessary to run several via blood transfusion and, rarely, patients, such as those being treated tests, and negative results should not through organ transplantation or for cancer or HIV infection and be used to rule out treatment.3
    [Show full text]
  • Toxoplasmosis
    Toxoplasmosis What is toxoplasmosis and Can I get toxoplasmosis? How can I protect my animal what causes it? Yes. People can get toxoplasmosis from toxoplasmosis? Toxoplasmosis (tox-ooh-plas- by ingesting (oral) Toxoplasma gondii Keep cats indoors to prevent moe-sis) is a disease caused by a from fecally contaminated (unwashed them from becoming infected microscopic protozoal parasite called raw) vegetables or under cooked or from shedding oocysts into Toxoplasma gondii (tox-ooh-plas- meat. It can also be spread by contact the environment. They should be ma gon-dee-eye). The organism has with feces from an infected cat. especially kept out of livestock areas. a complex life cycle. Toxoplasmosis Disease is rare in people who are Feed animals commercially prepared occurs worldwide. healthy. The greatest risk is to those foods. Raw or under cooked meats with weakened immune systems (e..g., should not be fed. Do not allow cat to What animals get persons with HIV/AIDS or pregnant hunt or eat wild rodents or birds. toxoplasmosis? women). How can I protect myself Many animal species can get Symptoms begin with mild, flu-like from toxoplasmosis? toxoplasmosis. Cats are required for signs (fever, body aches, headache, the life cycle of the organism. Infection sore throat). Severe disease can occur The risk of infection can be reduced is most common in cats, sheep, goats, if the protozoan invades the muscles, by proper food preparation. Meats and swine. Cattle seem to relatively nervous system, heart, lungs or eye. should be thoroughly cooked. Good resistant. Dogs can also be infected. The organism can cause abortion or hygiene is also important.
    [Show full text]